LONG-TERM INCENTIVE PLAN AWARDS (Tables)

6 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of stock option activity

						Weighted-
						Average
				Weighted-		Remaining
				Average		Contractual		Aggregate
				Exercise		Life		Intrinsic
Options	Shares			Price		(In Years)		Value
Outstanding as of June 30, 2022		766,001		$	3.85		3.37	$	183,270
Granted		–			–		–		–
Exercised		(100,000	)		1.34		–		–
Cancelled		–			–		–		–
Forfeited or expired		(16,000	)		5.40		–		–
Outstanding as of December 31, 2022		650,001		$	4.24		3.37	$	401,760
Exercisable as of December 31, 2022		352,475		$	4.68		3.05	$	134,898

The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based upon the Company’s closing stock price of $4.46 as of December 31, 2022, which would have been received by the option holders had all option holders exercised their options as of that date. The weighted-average grant-date fair value of stock options outstanding as of December 31, 2022, in the amount of 650,001 shares was $3.35 per share. As of December 31, 2022, there was unrecognized compensation cost of $905,275 related to non-vested stock options granted.

A summary of the status of our stock options s presented below as of December 31, 2021: 

						Weighted-
						Average
				Weighted-		Remaining
				Average		Contractual		Aggregate
				Exercise		Life		Intrinsic
Options	Shares			Price		(In Years)		Value
Outstanding as of June 30, 2021		484,000		$	3.67		2.83	$	2,662,830
Granted		388,000			3.38		–		–
Exercised		(3,999	)		5.40		–		–
Cancelled		–			–		–		–
Forfeited or expired		(5,000	)		5.40		–		–
Outstanding as of December 31, 2021		863,001		$	3.52		3.51	$	1,026,570
Exercisable as of December 31, 2021		329,115		$	2.84		1.76	$	644,472